Dyslipidemia

Skip to main content

This website is intended exclusively for healthcare professionals residing and/or working in Bahrain.

Dyslipidemia

Learn about the latest trends, discover events and innovations in the changing world of dyslipidemia disease.

Science in Dyslipidemia Disease

Get a 360º view and stay up-to-date on cardiovascular disease with content selected for you

ODYSSEY Outcomes

NEJM Odyssey Outcomes

Odyssey Outcomes - Mortality

Odyssey Outcomes - CABG Results

Odyssey Outcomes - PVD Results

Odyssey Outcomes - Elderly Patients Results

Odyssey Outcomes - Total Events Results

Odyssey Outcomes - DM sub-analysis

ESC/EAS 2019 International Guidelines

Odyssey Outcomes - Total Events Analysis

Odyssey Outcomes - PVD Sub-analysis

Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

Inspiration and innovation

Get inspired and stay at the forefront of innovation with the following resources

EAS guidance regarding combining lipid-modifying therapy

Lp(a) and PCSK9 inhibition in nominally controlled LDL-C

Treating to target in clinical practice: Why is it important to achieve recommended LDL-C levels?

Events

Stay up to date and register for the latest events and view webinar recordings.

Dyslipidemia Webinars: Optimizing Dyslipidemia management

Dyslipidemia Expert Exchange: Best practice approaches in dyslipidemia management

YOU WILL NOW BE LEAVING THE SITE

By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.

Continue

This website is intended exclusively for healthcare professionals residing and/or working in Bahrain.

Please choose if you are a healthcare professional and wish to continue on this site or if you are a member of the public to be redirected to the Sanofi website.